This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $435,782 to the Trustees of Indiana University to conduct research on the effects of tranexamic acid (TXA) on the pulmonary endothelium after thoracic trauma. The research aims to explore preserving endothelial integrity, which is critical for maintaining proper cardiovascular function. This 3-year award, with a start date of January 1, 2025 and an ultimate completion date of December 31, 2027, supports scientific investigation into potential therapeutic approaches for improving outcomes for military service members and the broader public affected by traumatic pulmonary injuries. The Military Medical Research and Development program funds a range of biomedical research across medical disciplines to advance health solutions for the military and general population.
Generated 2/25/25, 4:40 AM